Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Alzheimer’s Disease Savidra Lucatero, Vinita Mehrotra, Sabrina Rawlings, Jackie Wheeler, & Matt Zustiak.
Alzheimer Disease. The year 2006 is the centenary of the famous presentation of Alois Alzheimer which first described the neuropathology of Alzheimer’s.
Etiopathogenesis of Alzheimer's disease
This is only for personal educational purposes.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
Genetic Screening for Alzheimer’s Disease Thorstensen: Genetic Screening for Alzheimer's Disease 1.
1 ALZHEIMER’S DISEASE Treatment and Prevention Ben Best President/CEO Cryonics Institute.
ALZHEIMER'S DISEASE (AD)
Neurobiology of Learning and Memory Prof. Anagnostaras Lecture 10: Alzheimer’s Disease and Cognitive Decline in Aging.
CSF tau Is it an informative biomarker of AD pathology Chris Clark Alzheimer’s Disease Center University of Pennsylvania.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Pathology and Treatment
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
AGING AND TRAUMA Key Points Increased longevity results in increased neurological disorders ‘Normal’ age-related changes in brain structure Neurodegenerative.
Alzheimer's disease Beta amyloid protein and the potential for anti-oxidants drugs.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
2 Huntington’s disease Parkinson’s disease Amylotrophic lateral sclerosis Alzheimer’s Disease Neurodegenerative Disorders.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
ACH: Involvement in diseases Myasthenia gravis Symptoms: loss muscular tonus progression from head to limbs to respiratory muscles.
Nature may have the answers for Alzheimer’s disease Sungkwon Chung Dept. of Physiology Sungkyunkwan University School of Medicine.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Progress Report on Alzheimer’s Disease Taking the Next Steps NIA NIH.
Alzheimer’s Disease Causes, Effects, and Treatments.
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Molecular mechanism for Alzheimer’s disease : searching for the possible therapeutic targets Sungkwon Chung Dept. of Physiology Sungkyunkwan Univ. School.
1 Alzheimer’s Disease & Acetylcholine Presentation by: Huy Nguyen Chemistry 12B Instructor: Dr. Adamczeski Fall-2006.
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
ALZHIEMERS DISEASE IN UK ‘’The Dementia Time bomb’’ By VISHAL ZAVERI AND ORE AJAI.
National Institute on Aging
CLINICAL AND RESEARCH MEMORY CENTER LARIBOISIERE HOSPITAL PARIS FRANCE UNIVERSITY OF PARIS DIDEROT INSERM UNIT 942 INVOLVEMENT OF PKR IN ALZHEIMER’S DISEASE.
Alzheimer’s Disease Gavin Mast, Musa Abdus-Samad, Arash Rezaeian, Sarah Rocha PHM142 Fall 2015 Instructor: Dr. Jeffrey Henderson.
Epidemiology of Alzheimer’s Disease
Under the supervision of miklós jászberényi
Alzheimer's disease M O Jamali, H Saeed & T Mathew.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Alzheimer’s Disease By:Jeorzsees Ang, Becky Carrasco, Eunice Choi, and Deborah De La Puente.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
Alzheimer’s Disease (AD)
Trends in Biomedical Science Theories of Alzheimer’s Disease.
Alzheimer’s Disease and the influence of Presenilin 1
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Alzheimer’s Disease and Cholesterol
Aging in the CNS.
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Alzheimer’s Disease.
Alzheimer’s Disease 1 in 9 people in the US aged 65 and older
Amnesia Syndromes Lecture 21.
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Progress Report on Alzheimer’s Disease
Disorders with Complex Genetics
Acetylation Unleashes Protein Demons of Dementia
Neurological Disorders
Drugs for Degenerative Diseases of the Nervous System
Alzheimer Mechanisms and Therapeutic Strategies
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences with AD Perception regarding ….. cause diagnosis treatments prevention

Alzheimer’s Disease (AD) - symptoms 1)Synaptic dysfunction in neurons hippocampus and amygdala (memory) 2)Decrease in # neurons – ↓ACh oxidative damage, inflammation, apoptosis 3) Cognitive decline - loss of new memories, memory loss, dementia 4) Autopsy findings Plaque containing A  42 aggregates NFTs (neurofibrilary tangles – tau protein) 2 million Americans: 10% > 65; 50% > 85

APP – Amyloid  A4 Protein 1) Neuron cell surface receptor (753 aa) 2) Neuron growth, cell motility/adhesion, axon generation 3)APP processing: 671-  -secretase 711- or 713-  -secretase → A  40 or A  42 A  42 > A  40 ↑AD likelihood 4) A  42 & A  40 binds to apoE (apolipoprotein E) 50% apoE4 allele in AD vs. 20% 5) A  42 & A  40 binds and reduces Cu 2+ /Zn 2+

Alzheimer’s Disease (AD) – Genetic Predisposition Early onset AD ….. 10% of AD victims 1)Down Syndrome – APP is located on chromosome 21 or APP mutations 2) PSEN1 & PSEN2 mutants – encodes  -secretase ↑A  42 over A  40 Late onset AD ….. >2x increase if have apoE4 allele

Tau protein & Tau hypothesis Tau binds to tubulin and helps to stabilize microtubules microtubules are important to axon function in neurons tau phosphorylation important to function) hyperphosphorylation induces tangles Debates over cause/effect relationship between A  42 and tau Calcium Hypothesis Presinilins are subunits of  -secretase Also function as ER Ca 2+ leak channels (independent of secretase activity) Defective presenilins lead to ↑Ca 2+ in ER evidence: abnormal Ca signaling in FAD patients with mutant presenilins

Alzheimer’s Disease (AD) – sequence The amyloid hypothesis? 1) APP → A  40 /A  42 faster than A  40/42 → aa: normal aging 2) A  42 oligomers accumulate in limbic cortexes 3) Synaptic dysfunction caused by A  42 oligomers? 4) A  plaque accumulation 5) Inflammation response in brain – microglial/astrocytes 6) Neuron dysfunction, oxidative stress, glutamate accumulation 7) Neurofibrillary tangles formed (tau) 8) 1 st symptoms - ↓neurons (apoptosis) - ↓ACh 9) Progressive cognitive decline → dementia

The Amyloid hypothesis A  42 oligomers is the causative agent in AD In animal models dementia correlates poorly with plaque increased tau tangles cause Parkinson’s-like symptoms. AD symptoms↑ as diffusible forms of A  oligomers↑. A  oligomers injected into rat brains inhibited LTP. Antibodies to A  oligomers enhanced LTP. Alternatives theories typically suggest multiple causes which include A  42 pathology but also include amyloid-independent mechanisms …. ↓NT release – altered signal transduction cascades – endo lysosomal trafficking deficiencies -

Alzheimer’s Disease (AD) – therapies AD detection problem 1) Ach esterase inhibitors 2)  -secretase inhibitors3)  -secretase inhibitors 4) A  oligomer antibodies 5) Anti-inflamatory drugs – e.g. NSAIDs 6) Statins – cholesterol lowering drugs (also anti-inflammatory) 7) Anti-oxidants – protect neurons & avoid inflammation 8) NMDA-R antagonists – counteract ↑glutamate 9) Chelating agents – aid in A  42 clearance?

Donepezil (Aricept) Acetylcholine Esterase Inhibitors O acetyl choline || CH 3 -C-O-CH 2 -CH 2 -N(CH 3 ) 3 + Huperzine A

Ach esterase – Huperzine A complex

How to avoid AD? Anti-hypertensive medication? Keep BP down Nutrition –  3 fatty acids – LDL↓ - weight↓ DHA protects against learning deficits in rat AD models in vitro – DNA inhibits A  fiber formation. Cognitive engagement – i.e. think!! Physical activity Why? 1 – prevents inflammation? 2 – healthy brain chemistry 3 – stimulates neural cell growth 4 – keeps BP/weight/LDL down,

Chadwick Article - prequiz 1. What was the primary conclusion of the article? 2.Describe the role of fMRI in the article? or …… What events were part of the film?

Cell Paper Amyloid aggregation sequesters proteins This results in loss of function failure to mount efficient stress response chromatin regulators (improper interactions with TFs) The  -protein interactors have certain characteristics large – flexible – disordered regions -